<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Immunology and Molecular Pathology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/BA08691A-0277-45FB-A759-056325F7766E"><gtr:id>BA08691A-0277-45FB-A759-056325F7766E</gtr:id><gtr:firstName>Arne</gtr:firstName><gtr:otherNames>Nalpon</gtr:otherNames><gtr:surname>Akbar</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/DF8CDE17-F780-4860-937C-9028020A8892"><gtr:id>DF8CDE17-F780-4860-937C-9028020A8892</gtr:id><gtr:firstName>Fiona</gtr:firstName><gtr:otherNames>Jane</gtr:otherNames><gtr:surname>Plunkett</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER_COI</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FE019188%2F1"><gtr:id>DF511799-D048-47D1-A642-EDAA6535EF8E</gtr:id><gtr:title>Telomerase downregulation in memory CD8+ T cells by cytokine and surface inhibitory receptor signalling</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/E019188/1</gtr:grantReference><gtr:abstractText>Old individuals are very susceptible to infections. This suggests that an immune defect occurs during ageing. However, the nature of this defect at the molecular level is not known. One of the key protective cells of the immune system is the cytotoxic T lymphocyte that is a very effective safeguard of our health in youth. However, these cells lose vigour as we age and this may explain the increased incidence of infection. To mount an immune response, there is a massive recruitment drive in order to mobilize the immune army. Recruitment increases the number of cytotoxic combatants that are essentail to clear the infection. This increase occurs as the cytotoxic cell is induced to divide and proliferate. Our previous data has shown that the cytotoxic cells from old individuals do not divide as well as those from young subjects because the activity of a crucial enzyme within these cells known as telomerase is lost. This enzyme confers unlimited proliferative capacity to cells. The studies that we propose here are to investigate the nature of the telomerase defect in old cytotoxic T cells, with a view to determine if thes changes are reversible. This has obvious implications for the improvement of health in old subjects. The studies that we hae proposed are based on our previous data that has been generated through BBSRC funding and is a logical follow-on of this work.</gtr:abstractText><gtr:technicalSummary>Ageing is associated with an accumulation of highly differentiated CD8+ T cells as defined by the loss of expression of the co-stimulatory receptors CD28 and CD27 and a lack of telomerase activity. Firstly we will investigate the mechanism of telomerase downregulation in highly differentiated CD8+ T cells. Akt is essential for the function of telomerase and our preliminary data suggests there is defective phosphorylation. We will purify CD8+CD28-27- T cells using the VARIOMACS and determine whether Akt is functional by analysing well known downstream targets using western blot analysis. This will indicate whether the lack of Akt phosphorylation is specific to hTERT function. Further analysis will also assess upstream regulators of Akt such as PDK-1. In addition, we will investigate the ability of the cytokines IL-2 and IL-15 to modulate survival, proliferation and telomerase induction of CD8+CD28-27- T cells. We have shown that IFN-a inhibits telomerase activity of CD8+ T cells. We will investigate whether this is through the transcriptional regulation of hTERT, Akt or PDK-1 or their phosphorylation status. We will also investigate the change in transcriptional profiles of genes associated with intracellular signalling pathways and telomerase activity before and after IFN-a treatment to enable a global assessment of telomerase-associated gene regulation. We will also analyse early and late differentiated CD8+ T cells with these methods. Finally we will explore the role that the surface molecule PD-1 has in the downregulation of telomerase activity. PD-1 is a negative regulator of T cell activation and is associated with 'exhausted' T cells. This molecule is known to inhibit the phosphorylation of Akt raising the possibility that it may directly induce telomerase downregulation. We will block PD-1 signalling in vitro in highly differentiated CD8+CD28-27- T cells and see if we can reverse the functional defects oberved.</gtr:technicalSummary><gtr:fund><gtr:end>2010-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2007-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>403102</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs><gtr:artisticAndCreativeProductOutput><gtr:description>Video of Research Activities in The Akbar Group</gtr:description><gtr:id>16786577-975B-4A44-8ECD-BE5165FEB53C</gtr:id><gtr:impact>The film is used by the Akbar laboratory and its members when advertising our research and its impact. It has been shown at public engagement events and used when advertising new opportunities to join the group.</gtr:impact><gtr:outcomeId>56dd95268c4013.55400982</gtr:outcomeId><gtr:title>Akbar Film</gtr:title><gtr:type>Film/Video/Animation</gtr:type><gtr:url>https://youtu.be/l_426Pamxcc</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput></gtr:artisticAndCreativeProductOutputs><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>36000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UK/USA partnership grant</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/G530433-1</gtr:fundingRef><gtr:id>7A3DA43C-35D6-451C-8419-4B5BAE0853CE</gtr:id><gtr:outcomeId>5ee4ce585ee4ce76</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Patent PCT-GB2012-052948: Immuno-stimulatory co-therapy</gtr:description><gtr:grantRef>BB/E019188/1</gtr:grantRef><gtr:id>247BC3F2-7818-4FEC-89AB-33C429C82D87</gtr:id><gtr:licensed>No</gtr:licensed><gtr:outcomeId>m-5230657900.89839976689cc4</gtr:outcomeId><gtr:patentId>PCT/GB2012/052948</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Blocking senescence and exhaustion</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:keyFindingsOutput><gtr:description>The first aim of this project was to investigate reasons why telomerase is down-regulated in highly differentiated human T cells. We found that the signalling kinase Akt, that is required for activating hTERT, the catalytic component of telomerase was not phosphorylated in highly differentiated CD8+ T cells. 

The second aim of the grant was to determine whether telomerase down regulation can be counteracted by the cytokines IL-2 and IL15. We have found that we can increase telomerase activity in highly differentiated CD8+ T cells to a limited extent by both these cytokines. This indicates that other mechanisms are responsible for the decrease in activity of this enzyme and shows that cell survival and cellular senescence in human CD8+ T cells can be regulated separately.

Furthermore, we found that by blocking KLRG-1 signalling we could enhance the proliferation and Akt phosphorylation of highly differentiated CD8+ T cells. However, we could not alter the reduced expression of telomerase or IL-2 secretion by these populations. This indicates that some but not all the defective functions that are found in highly differentiated CD8+ T cells can be regulated by inhibitory receptors on the cell surface.</gtr:description><gtr:exploitationPathways>We identified signalling pathways that may be manipulated to boost immunity in older individuals. This information has led to investigation of P38 signalling that contributed to the patent filed (PCT -GB2012-052948)</gtr:exploitationPathways><gtr:id>8F961744-CC70-49E6-AAA4-90320FB93F60</gtr:id><gtr:outcomeId>r-3786399191.04650557782415c</gtr:outcomeId><gtr:sectors><gtr:sector>Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C60CC8D2-1D3D-4259-BB17-3AACBE088625</gtr:id><gtr:title>Cytomegalovirus infection induces the accumulation of short-lived, multifunctional CD4+CD45RA+CD27+ T cells: the potential involvement of interleukin-7 in this process.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d4abefe8b50cd360610b80cdf07d3f6"><gtr:id>9d4abefe8b50cd360610b80cdf07d3f6</gtr:id><gtr:otherNames>Libri V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>pm_5435ac05ac0d56775</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0420EF36-7C0E-4667-A411-A64B6DBC89E1</gtr:id><gtr:title>The Loss of Telomerase Activity in Highly Differentiated CD8+CD28-CD27- T Cells Is Associated with Decreased Akt (Ser473) Phosphorylation</gtr:title><gtr:parentPublicationTitle>The Journal of Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ad4981ee01ae759f5cf7e2d7305cdeb"><gtr:id>5ad4981ee01ae759f5cf7e2d7305cdeb</gtr:id><gtr:otherNames>Plunkett F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:outcomeId>doi_53d08908908da696</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AFBB34D-C6DF-4FB2-BB2D-64394B6683AD</gtr:id><gtr:title>Senescence of T Lymphocytes: Implications for Enhancing Human Immunity.</gtr:title><gtr:parentPublicationTitle>Trends in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d093bf67744b4df4103599799dfa918"><gtr:id>4d093bf67744b4df4103599799dfa918</gtr:id><gtr:otherNames>Akbar AN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-4906</gtr:issn><gtr:outcomeId>58ad9f21671ad4.57968754</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAC7CC1D-4CB3-4816-9930-164CA628F553</gtr:id><gtr:title>Reversible senescence in human CD4+CD45RA+CD27- memory T cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15266bc89d41e55f4ee8326a3e110f0b"><gtr:id>15266bc89d41e55f4ee8326a3e110f0b</gtr:id><gtr:otherNames>Di Mitri D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_5435ac15ac10da81a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21D52C7B-737D-40A6-B65C-D96C84FA9EFA</gtr:id><gtr:title>The convergence of senescence and nutrient sensing during lymphocyte ageing.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d093bf67744b4df4103599799dfa918"><gtr:id>4d093bf67744b4df4103599799dfa918</gtr:id><gtr:otherNames>Akbar AN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>58ad9f21b4fd28.19590853</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15B59896-538D-4959-A6DE-35D402666F85</gtr:id><gtr:title>The loss of telomerase activity in highly differentiated CD8+CD28-CD27- T cells is associated with decreased Akt (Ser473) phosphorylation.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95d61a5caf89cbaa4d2611ff4c1f57a1"><gtr:id>95d61a5caf89cbaa4d2611ff4c1f57a1</gtr:id><gtr:otherNames>Plunkett FJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_5435ac15ac11b6205</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15E8BBF8-B524-4636-9C56-76F1A418458A</gtr:id><gtr:title>Human cytomegalovirus-specific CD8(+) T-cell expansions contain long-lived cells that retain functional capacity in both young and elderly subjects.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2beb0e5d39626113f74b8a15a597e4d6"><gtr:id>2beb0e5d39626113f74b8a15a597e4d6</gtr:id><gtr:otherNames>Wallace DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>pm_5435ac05ac0ea7c6c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4226BC5-D0BF-42D0-A632-216AE14CFA25</gtr:id><gtr:title>Convergence of Innate and Adaptive Immunity during Human Aging.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88085f9fe6a937756181be4d679456ac"><gtr:id>88085f9fe6a937756181be4d679456ac</gtr:id><gtr:otherNames>Pereira BI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>58ad9f21448fc7.97119930</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28010B39-9AA2-4E58-93F6-D7D697462E3D</gtr:id><gtr:title>A sestrin-dependent Erk-Jnk-p38 MAPK activation complex inhibits immunity during aging.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/496b74cea6ae4d30e25e1e0e77e10e73"><gtr:id>496b74cea6ae4d30e25e1e0e77e10e73</gtr:id><gtr:otherNames>Lanna A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>58ad9f21d5c527.17966496</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93B032A6-ACFD-4FA1-AEF2-47A045596FF6</gtr:id><gtr:title>Killer Cell Lectin-like Receptor G1 Inhibits NK Cell Function through Activation of Adenosine 5'-Monophosphate-Activated Protein Kinase.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c01242016d7b2b3530e7901f3a2971a"><gtr:id>5c01242016d7b2b3530e7901f3a2971a</gtr:id><gtr:otherNames>M?ller-Durovic B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>58ad9f21182748.82132234</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BA65D6C-AC94-4693-8638-C800DD530D2F</gtr:id><gtr:title>Age-associated increase of low-avidity cytomegalovirus-specific CD8+ T cells that re-express CD45RA.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e8e620d7475dd142e4954247b874be1"><gtr:id>0e8e620d7475dd142e4954247b874be1</gtr:id><gtr:otherNames>Griffiths SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5675d84cebe80</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAD4B1F6-F28F-46BE-94B8-09D0691528CE</gtr:id><gtr:title>KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eeadefcfa805429fe4021215f24d5f0f"><gtr:id>eeadefcfa805429fe4021215f24d5f0f</gtr:id><gtr:otherNames>Henson SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_5435ac05ac0f80f8a</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/E019188/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>